Pfizer Inc PFE:NYSE

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 7:59 PM EDT
48.24quote price arrow down-0.05 (-0.10%)
Volume
1,600,645
Close
48.29quote price arrow down-1.66 (-3.32%)
Volume
41,290,098
52 week range
40.94 - 61.71
Loading...
  • Open48.22
  • Day High49.13
  • Day Low47.81
  • Prev Close49.95
  • 52 Week High61.71
  • 52 Week High Date12/20/21
  • 52 Week Low40.94
  • 52 Week Low Date10/13/21

Key Stats

  • Market Cap270.95B
  • Shares Out5.611B
  • 10 Day Average Volume19.70M
  • Dividend1.60
  • Dividend Yield3.31%
  • Beta0.66
  • YTD % Change-18.22

KEY STATS

  • Open48.22
  • Day High49.13
  • Day Low47.81
  • Prev Close49.95
  • 52 Week High61.71
  • 52 Week High Date12/20/21
  • 52 Week Low40.94
  • 52 Week Low Date10/13/21
  • Market Cap270.95B
  • Shares Out5.611B
  • 10 Day Average Volume19.70M
  • Dividend1.60
  • Dividend Yield3.31%
  • Beta0.66
  • YTD % Change-18.22

RATIOS/PROFITABILITY

  • EPS (TTM)5.19
  • P/E (TTM)9.31
  • Fwd P/E (NTM)7.88
  • EBITDA (TTM)41.859B
  • ROE (TTM)33.66%
  • Revenue (TTM)101.132B
  • Gross Margin (TTM)62.21%
  • Net Margin (TTM)29.44%
  • Debt To Equity (MRQ)44.04%

EVENTS

  • Earnings Date10/31/2022(est)
  • Ex Div Date07/28/2022
  • Div Amount0.40
  • Split Date-
  • Split Factor-

Related Video

VIDEO2:1102:11
BMO's Evan Seigerman breaks down the Zantac trial

Profile

MORE
Pfizer Inc. (Pfizer) is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products. Its global portfolio includes medicines and vaccines. The Company offers therapeutic candidates in gastroenterology, dermatology, and cardiology, including etrasimod, an oral, selective sphingosine 1-phosphate (S1P) receptor modulator in development for a range of...
Albert Bourla Ph.D.
Chairman of the Board, Chief Executive Officer
David Denton
Executive Vice President, Chief Financial Officer
Aamir Malik
Executive Vice President, Chief Business Innovation Officer
Lidia Fonseca Ph.D.
Executive Vice President, Chief Digital and Technology Officer
Douglas Lankler
Executive Vice President, General Counsel
Address
235 E 42ND ST
New York, NY
10017-5703
United States

Top Peers

SYMBOLLASTCHG%CHG
RHHBY
Roche Holding AG
41.04-1.05-2.49%
ABBV
Abbvie Inc
142.08+1.14+0.81%
MRK
Merck & Co Inc
88.93-0.26-0.29%
JNJ
Johnson & Johnson
167.14-3.53-2.07%
LLY
Eli Lilly and Co
301.17-3.44-1.13%